A Woman With Syncope and Severe, Progressive Headaches
Jennifer Koterwas MS IV, Hind Rahmouni MD, Joanna Kipnes MD
Case Report

A 61 year-old female who was status post-gastrectomy and
chemotherapy for gastric cancer presented to the emergency
department with complaints of two syncopal episodes and
ongoing headaches for the last month. Her syncopal episodes
occurred on the day of admission and five days prior and were
preceded by shaking, dizziness, and a feeling of being in a
“different dimension.” The losses of consciousnesses lasted for
several minutes and were accompanied by shaking, but were not
associated with any urinary or bowel incontinence or tongue
biting. The patient denied any fevers or new medications,
and felt that the episodes were not associated with a specific
activity or time of day. The patient also complained of new
onset headaches that had progressed in frequency over the last
month from being present for only a few minutes a day to being
present for the entire day. The headaches were described as
a “brain freeze,” with 10 out of 10 pain that was not relieved
by acetaminophen with codeine, ibuprofen, or morphine. The
headaches were non-radiating and diffusely located throughout
the head. The headaches were exacerbated by movement, and
associated with an increase in nausea and vomiting. The patient
did not have any lacrimation or rhinorrhea, and she denied any
past history of migraines, head trauma, or neck pain. Review of
systems was negative except for a progressive increase in blurry
vision with occasional white spots in her vision over the last
three weeks. One week prior to admission she had an outpatient
brain MRI (Figure 1a) done, and two days ago a head CT both of
which showed no evidence of metastatic disease, hemorrhage,
infarct, or mass lesion.

normal physical exam, EKG, and echocardiogram. Dehydration
was suspected based on the patient’s orthostatic heart rate
changes and poor dietary intake. Cerebral vasospasm was
thought to be high on the differential for the most likely cause
of her headaches also because of unconcerning imaging and
unusual presentation.
Seizures appeared to be the most likely cause of her loss of
consciousness so an EEG was performed. The EEG revealed
focal slow waves greater on the left mid-temporal region than
the right and frontal intermittent rhythmic delta activity. Fluid
resuscitation was initiated and neurology was consulted to
help with diagnosis and treatment. Following the neurologist’s
recommendation, an MRA of the brain was ordered which
revealed no evidence of cerebral artery stenosis or aneurysms.
As there was no improvement in the patient’s symptoms, a
lumbar puncture was performed on hospital day three which
revealed a non-specific pattern of an elevated opening pressure
of 24 mm H2O, elevated cerebral spinal fluid (CSF) protein
of 114mg/dL, and a normal glucose of 43 mg/dL. On hospital
day six the patient became acutely confused, lethargic, and no
longer oriented to time. Absence seizures were witnessed by the
nurses. Her delirium continued to progress with agitation and

Past medical history was significant for gastric adenocarcinoma
(linitus plastica) status-post gastrectomy 3 months ago and
neoadjuvant chemotherapy with the last dose 3 weeks ago. The
patient was on her fifth week of radiation therapy out of six weeks.
Her current medications included as needed acetaminophen
with codeine, ibuprofen, prochlorperazine, and lorazepam.
On presentation the patient was afebrile with a temperature of
96.4°F, and had a respiratory rate of 18 breaths/minute. She had
orthostatic heart rate changes as demonstrated by an increase
in her heart rate from 87 bpm while supine to 101 bpm while
standing. Her supine blood pressure was 160/100 and her standing
blood pressure was 177/107. She was fully oriented to person,
place, and time. The patient had no nuchal rigidity, nystagmus,
or focal neurologic signs. Her cranial nerves, motor, sensory, and
cerebellar functions were all intact. Reflexes were 2+ bilaterally in
the upper and lower extremities and gait was normal.
The patient was admitted for a workup of syncope associated
with severe, progressive headaches. Intracranial bleeding or
a brain tumor was lower on the differential given the recent
normal head CT and brain MRI. A cardiac etiology was also
unlikely based on the negative history of cardiac disease and a

Figure 1a. Initial MRI of the brain showing no evidence of
metastatic disease, hemorrhage, infarct, or mass lesion.
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new onset hallucinations and delusions. She also developed an
unstable gait, and a new right cranial nerve six palsy. Due to her
rapidly declining condition, dexamethasone was started.
Ophthalmology was consulted to examine the patient’s
visual changes and to evaluate for papilledema due to her
elevated opening pressure on the lumbar puncture. On
exam, a choroidal lesion was detected that was suspicious for
metastasis. The same day, CSF cytology results came back
from the initial lumbar puncture revealing atypical cells highly
suspicious for cancer of an unknown primary. The results of
the lumbar puncture cytology and the suspected metastatic
choroidal lesion prompted a repeat MRI and lumbar puncture.
The results from the repeat MRI revealed increased FLAIR and
enhancement in the subarachnoid space (Figure 1b). The repeat
lumbar puncture revealed an elevated opening pressure of 36
mm H2O, elevated fluid protein of 93 mg/dL, and a low glucose
level of 37 mg/dL, findings which were more consistent with
metastatic cancer. The repeat CSF cytology revealed malignant
cells consistent with metastatic adenocarcinoma (Figure 2).
Both results supported the diagnosis of leptomeningeal carcinomatosis (LC) secondary to linitis plastica adenocarcinoma. The
patient was started on corticosteroids.

Figure 2. CSF cytology revealing epithelial cells with
hyperchromatic and irregularly contoured nuclei, vacuolated
cytoplasms, and high nuclear to cytoplasmic ratios. These
features are consistent with metastatic adenocarcinoma.
On the ninth day of her hospital course and the third day of
steroids, the patient’s mental status markedly improved to
being fully oriented to person, time, and place with only mild
confusion. Her headache also improved and was now present
transiently following her steroid treatments. She was able to
understand her diagnosis and treatment options, and elected
to begin a 5-day course of whole brain radiation followed
by intrathecal chemotherapy. Her mental status returned to
baseline and she was discharged home on hospital day11.

Discussion

Linitis plastica is a poorly differentiated gastric adenocarcinoma
that infiltrates the gastric wall and is commonly associated
with peritoneal and lymph node metastases. Histologically,
linitis plastica is characterized by signet ring cells along with
a marked fibroblastic stroma reaction.3 Interestingly, LC arises
in only 3% to 8% of all solid cancers and most frequently in
patients with leukemia, breast cancer, lymphoma, melanoma,
and lung cancer.1,3 The incidence of LC due to gastric cancer
is 0.06%, although the diagnosis may be on the rise due to an
increased survival time in gastric cancer patients.2,4 Advanced
gastric cancer patients classified as Borrmann type III and IV
which includes linitis plastica, have higher rates of developing
LC when compared to those with early disease. The majority of
patients are diagnosed during the treatment of primary gastric
cancer as seen in our patient.1,7

Figure 1b. MRI of the brain, performed two weeks after
the first MRI, revealing increased FLAIR signal in the sulci
(arrows) and increased enhancement in the subarachnoid
space, suggestive of leptomeningeal carcinomatosis.
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Extra-abdominal metastasis occurs in less than 13% of gastric
cancer patients with the majority of cases spreading hematogenously to the lung or bone. Although still debated, it is believed
that the Batson’s venous plexus which consists of longitudinally
oriented, valveless paraspinal veins may be the primary route for

tumor cells to reach the subarachnoid space.1,9 Another theory
postulates that the gastric cancer spreads by direct extension
along peripheral nerves to the subarachnoid space. Once the
cancer reaches the leptomeninges and subarachnoid space it
has access to all regions of the central nervous system, leading
to a variety of nonspecific signs and symptoms. LC’s clinical
presentations are variable, ranging from isolated to multiple
central nervous system, spinal, and cranial nerve symptoms
and signs.1 Some common clinical symptoms and signs include
headaches, nausea, vomiting, altered mental status, seizures,
cranial nerve palsie, visual changes, limb weaknesses, and speech
difficulties.3,4 LC is difficult to diagnose not only because of the
variety of presentations, but also because many of the symptoms
resemble common chemotherapeutic induced side-effects, for
example nausea, vomiting, sensory loss, hearing loss, vertigo,
and nystagmus.1,10
Unfortunately there is no single laboratory test or imaging study
that is capable of detecting all cases of LC. Diagnosis for LC rests
on CSF cytology. The sensitivity of a single lumbar puncture
in the detection of atypical cells diagnostic for LC is 54%, but
higher sensitivities can be obtained through repeated tests.4 The
sensitivity of LC increases to 75% after two lumbar punctures,
and up to 85% after three lumbar punctures.6 Other CSF results
suggestive of LC include: increased opening CSF pressure,
increased CSF cellularity, elevated protein CSF content, and
decreased CSF glucose concentration.4 The patient described
in this case study had an increased CSF pressure, increased
protein, and a decreased glucose consistent with the eventual
diagnosis of LC.
The imaging study of choice for leptomeningeal carcinomatosis
is an MRI of the brain, which characteristically shows focal areas
of linear meningeal enhancement in a nodular pattern. The
MRI sensitivity for detecting LC however ranges only from 66%
to 77%. Given the low sensitivity of both CSF cytology and MRI
when used alone, it has been reported that up to 18% of patients
with LC are likely missed.4 The patient described in this case
fell into this category because her diagnosis was missed initially
based on her first MRI. Contrast enhanced CT scans are also
commonly used to evaluate patients but it should be noted that
at most the sensitivity is only 44%.4
Unfortunately, the prognosis of LC secondary to gastric cancer
is poor with a mean survival of four to six weeks for those

who do not receive treatment and a mean survival of two to
six months for those who receive treatment.1,2,4 Some factors
that favor survival are a good performance status, a response
to intrathecal chemotherapy, a low CSF lactate dehydrogenase
concentration, and minimal neurological symptoms.1,7 The
dismal prognosis of LC in the setting of gastric cancer stresses
the importance of early diagnosis because early palliative
treatment may help to improve quality of life. A high clinical
suspicion is necessary to diagnose LC secondary to gastric
cancer due to its nonspecific symptoms, low sensitivity tests,
and rare association with gastric cancer. Therefore, even when
imaging studies are not supportive as in the above case, the
diagnosis of LC should not be ruled out and repeat studies such
as a lumbar puncture should be considered. Although only a few
cases of intraocular metastasis of gastric adenocarcinoma have
been reported, a thorough ophthalmologic exam should also be
considered especially in patients with new-onset visual changes
as it may reveal metastasis (as in this case) and help to expedite
the diagnosis.8
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